Recherche
-
The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models
(Neuroscience and Biobehavioral Reviews. vol. 132, pp. 664-678, 2022-01)Article de revueLibre accès -
Normal-Appearing White Matter Integrity Is a Predictor of Outcome after Ischemic Stroke
(Stroke. vol. 51, n° 2, pp. 449-456, 2020-02)Article de revueLibre accès -
GRK2‐ Targeted Knockdown as Therapy for Multiple System Atrophy
(Movement Disorders. vol. 38, n° 7, pp. 1336-1340, 2023-07)Article de revueLibre accès -
Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum Disorder
(Neurology. vol. 101, n° 4, pp. E438-E450, 2023-07-25)Article de revue -
Differential vulnerability of thalamic nuclei in multiple sclerosis
(Multiple Sclerosis Journal, 2022-08-12)Article de revueLibre accès -
DeepLesionBrain: Towards a broader deep-learning generalization for multiple sclerosis lesion segmentation
(2022-06-13)Document de travail - Pré-publicationLibre accès -
Validation of a Denoising Method Using Deep Learning-Based Reconstruction to Quantify Multiple Sclerosis Lesion Load on Fast FLAIR Imaging.
(American Journal of Neuroradiology. vol. 43, n° 8, pp. 1099-1106, 2022-07-28)Article de revueLibre accès -
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
(Nature Medicine. vol. 29, n° 6, pp. 1487-1499, 2023-06-01)Article de revueLibre accès -
NMDARs, coincidence detectors of astrocytic and neuronal activities
(International journal of molecular sciences. vol. 22, n° 14, 2021-07-06)Article de revueLibre accès -
Severity of Small Vessel Disease Biomarkers Reduces the Magnitude of Cognitive Recovery after Ischemic Stroke
(Cerebrovascular Diseases. vol. 50, n° 4, pp. 456-463, 2021-04-07)Article de revue